Quantum research gets a boost at Sandia
DOE has awarded Sandia and Los Alamos national laboratories $8 million for quantum research — the study of the fundamental physics of all matter — at the Center for Integrated Nanotechnologies. The award will fund two three-year projects enabling scientists at the two labs to build advanced tools for nanotechnology research and development.
Nobel Laureate underscores CINT annual meeting
Nobel laureate Sir Fraser Stoddart gave the plenary address at the annual meeting of the Center for Integrated Nanotechnologies, which took place Sept. 24-25 in Santa Fe. This year’s conference highlighted research performed by the CINT user community in the areas of quantum materials, nano-mechanics and imaging.
Q&A with 2019 Truman Fellows
Sandia will welcome two new Truman Fellows in October. Pauli Kehayias and Thomas O’Connor will join the Labs for the next three years to apply breakthroughs they have made in their respective fields to Sandia applications.
A splash of detergent makes catalytic compounds more powerful
Uniform catalytic compounds produced at Sandia don't just look nice, they outperform commercial varieties used as catalysts in solar cells and which could be used to produce clean-burning hydrogen fuel. If developed for industry, the new technology could improve performance while reducing costs of catalysts used everywhere from environmental cleanup to cancer treatment.
First wind blade from a 3-D printed mold, energy-saving nanoparticles earn Sandia national FLC awards
Sandia’s energy-saving nanomaterial window films and first wind turbine blades made from a 3-D printed mold earn national honors from the Federal Laboratory Consortium
Magnetic nanoparticles leap from lab bench to breast cancer clinical trials
Dale Huber has been working on the challenge of making iron-based nanoparticles the exact same size for 15 years. Now, the Sandia materials chemist and his long-term collaborators at Imagion Biosystems will use these magnetic nanoparticles for their first breast cancer clinical trial later this year.
